SDGR

#2391
Schrodinger, Inc. - Common Stock
15.2 0 USD
+7.57%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
14.82
15.43
Range Annuel
10.95
27.63
Changement quotidien
+7.57%
Changement Mensuel
+28.81%
Evolution sur 6 mois
-12.14%
Changement Annuel
-28.67%
Clôture Précédente
14.1 3
Open
14.8 9
Low
14.8 2
High
15.4 3
Volume
906
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 1.14 B
  • Employee 850
  • Founded 1990
  • CEO Ramy Farid
  • Website www.schrodinger.com
  • Headquarter Delaware, United States
  • FIGI BBG000T88BN2
  • Industry Services d'Information sur la Santé
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-12.68
ratio cours/chiffre d'affaires
5.13

Schrodinger, Inc. - Common Stock

Schrödinger, Inc. is an international scientific software and biotechnology company that specializes in developing computational tools and software for drug discovery and materials science. Schrödinger's software is used by pharmaceutical companies, biotech, tech, chemicals, energy, aerospace firms, and academic researchers to simulate and model the behavior of molecules at the atomic level. This accelerates the design and develops new drugs and materials more efficiently, reducing the time and cost of bringing them to market. Schrödinger's software tools include molecular dynamics simulations, free energy calculations, quantum mechanics calculations, and virtual screening tools. The company also offers consulting services and collaborates with partners in the industry to advance the field of computational chemistry and drug discovery.

Nouvelles